And recent research demonstrated that high expression of CD44 is highly correlated with increased aggressiveness of pancreatic cancer and increased gemcitabine resistance to chemo chemicals (Zhao et al., 2016). This evidence concerns the gene CD44 and pancreatic neoplasm.